Drug Shortage Report for IBAVYR
Report ID | 101774 |
Drug Identification Number | 02439212 |
Brand name | IBAVYR |
Common or Proper name | ribavirine USP |
Company Name | PENDOPHARM DIVISION OF PHARMASCIENCE INC |
Market Status | DORMANT |
Active Ingredient(s) | RIBAVIRIN |
Strength(s) | 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 tabs |
ATC code | J05AP |
ATC description | |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-12-19 |
Actual start date | |
Estimated end date | 2020-01-17 |
Actual end date | 2020-01-20 |
Shortage status | Resolved |
Updated date | 2020-03-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-03-11 | French | Compare |
v4 | 2020-03-11 | English | Compare |
v3 | 2019-12-20 | English | Compare |
v2 | 2019-12-19 | French | Compare |
v1 | 2019-12-19 | English | Compare |
Showing 1 to 5 of 5